Latest headlines
Moderna News
The latest Moderna (MRNA) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these MRNA headlines next to the live Moderna Fear and Greed Index.
Latest Moderna Headlines60
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout
247wallst.com · Jul 10, 2026
Moderna wins EU contract for RSV vaccine supply
reuters.com · Jul 9, 2026
Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
accessnewswire.com · Jul 9, 2026
Moderna Appoints Michael McDonnell to Board of Directors
accessnewswire.com · Jul 8, 2026
Moderna Stock Is Soaring. Is It Too Late to Buy?
fool.com · Jul 7, 2026
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
zacks.com · Jul 6, 2026
These 3 Stocks Trounced the S&P 500 in the First Half of 2026 -- and Wall Street Thinks 1 of Them Could Soar Even More
fool.com · Jul 6, 2026
2 More Stocks to Buy for the AI Convergence
investorplace.com · Jul 5, 2026
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%.
fool.com · Jul 3, 2026
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?
zacks.com · Jul 3, 2026
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
fool.com · Jul 3, 2026
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
fool.com · Jul 3, 2026
Moderna stock jumps as pipeline progress and flu shot data lift sentiment
invezz.com · Jul 2, 2026
Short Squeeze Alert—Moderna Stock Surges on New Strategy
marketbeat.com · Jul 1, 2026
Is Moderna Stock a No-Brainer Buy After a Key FDA Win?
fool.com · Jun 30, 2026
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
zacks.com · Jun 29, 2026
Stock Of The Day: Will The Moderna Rally Continue?
benzinga.com · Jun 29, 2026
Moderna stock soars as cancer pipeline and CAR-T push ignite optimism
invezz.com · Jun 26, 2026
Moderna Is Up 13% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?
247wallst.com · Jun 26, 2026
Why Moderna Stock Is Soaring and Leading the S&P 500 Today
barrons.com · Jun 26, 2026
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
feeds.newsfilecorp.com · Jun 26, 2026
This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst
fool.com · Jun 26, 2026
Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript
seekingalpha.com · Jun 25, 2026
Moderna Science Day Highlights Expanding Potential of mRNA Platform
accessnewswire.com · Jun 25, 2026
Moderna (MRNA) Rises As Market Takes a Dip: Key Facts
zacks.com · Jun 23, 2026
Major Indexes Continue Lower as Chip Selloff Drags Nasdaq
schaeffersresearch.com · Jun 23, 2026
Should You Buy Moderna Before Aug. 5?
fool.com · Jun 22, 2026
Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?
fool.com · Jun 20, 2026
MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing
zacks.com · Jun 19, 2026
FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine
wsj.com · Jun 18, 2026
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine
accessnewswire.com · Jun 18, 2026
US FDA advisers vote in favor of Moderna's flu vaccine
reuters.com · Jun 18, 2026
Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny
reuters.com · Jun 18, 2026
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead
fool.com · Jun 18, 2026
MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns
zacks.com · Jun 17, 2026
Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains?
zacks.com · Jun 17, 2026
FDA Panel Set To Debate Moderna Flu Shot
benzinga.com · Jun 17, 2026
Moderna to Host Investor Event - Science Day
accessnewswire.com · Jun 17, 2026
Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO
reuters.com · Jun 17, 2026
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
247wallst.com · Jun 16, 2026
Moderna Strengthens Commercial Strategy As Pipeline Advances
benzinga.com · Jun 16, 2026
US FDA staff says data may support effectiveness of Moderna's flu vaccine in older adults
reuters.com · Jun 16, 2026
Moderna announces executive changes ahead of potential launches
reuters.com · Jun 16, 2026
Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028
accessnewswire.com · Jun 16, 2026
Moderna, Inc. (MRNA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com · Jun 9, 2026
Does Moderna Need to Start Making Money?
fool.com · Jun 9, 2026
Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome
accessnewswire.com · Jun 8, 2026
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
fool.com · Jun 3, 2026
Moderna Launches Moderna Direct with “eCommerce Powered by FFF Enterprises™”
globenewswire.com · Jun 2, 2026
MRNA Partners With CEPI to Develop Vaccine for Bundibugyo Ebolavirus
zacks.com · Jun 2, 2026
Moderna to Present at Upcoming Conference in June 2026
accessnewswire.com · Jun 2, 2026
Moderna, Inc. (MRNA) Discusses Intismeran mRNA Immunotherapy and Phase II KEYNOTE-942 Oncology Data Transcript
seekingalpha.com · Jun 2, 2026
Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls
benzinga.com · Jun 1, 2026
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
accessnewswire.com · Jun 1, 2026
Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine
reuters.com · Jun 1, 2026
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
accessnewswire.com · Jun 1, 2026
Moderna, Inc. (MRNA) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
seekingalpha.com · May 30, 2026
Moderna, Merck cancer combo cuts melanoma spread risk at five years
reuters.com · May 21, 2026
US FDA to hold expert committee meeting to review Moderna's flu vaccine
reuters.com · May 21, 2026
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
247wallst.com · May 21, 2026
Why Is Moderna Up or Down Today?
When Moderna (MRNA) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a MRNA move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Moderna is up or down today.
How Moderna News Affects the Price
News does not move the Moderna (MRNA) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Moderna Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Moderna trading volume. That is the chain to watch: headline, sentiment, volume, then the MRNA price.
Trade the Moderna News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Moderna trading volume spike on a big story, check the Moderna price history for context, follow the live MRNA price, see the Moderna price prediction, and read the Moderna Fear and Greed Index for mood.
How do you feel about Moderna?
1DFrequently asked questions
Why is Moderna up or down today?
What is the latest Moderna news?
Where does Moderna news come from?
How often is Moderna news updated?
How does Moderna news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.